Search research articles
Contact Us
Filters
Showing results (201-210 of 211) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers
M Nishio, T Koshikawa, T Kuroishi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 18, 2005
Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer
Y Ohe, S Negoro, K Matsui, et al.
Journal of Neuroendocrinology
|
October 2, 2001
Polyamine regulation of the rat pro-opiomelanocortin gene expression in AtT-20 cells
E Yamamori, Y Iwasaki, Y Aoki, et al.
International Journal of Hematology
|
October 1, 1996
Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16. MST-16 Study Group
Y Kagami, Y Ariyoshi, A Horiuchi, et al.
Journal of the National Cancer Institute
|
October 28, 1998
Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer
T Mitsudomi, S Suzuki, Y Yatabe, et al.
Cancer Chemotherapy Reports
|
June 1, 1972
Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man
K Ota, S Kurita, M Nishimura, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1982
The response to endocrine therapy in patients with advanced breast cancer in Great Britain and Japan
J L Hayward, R D Rubens, S Sexton, et al.
British Journal of Cancer
|
January 8, 2004
Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)
N Yamamoto, M Fukuoka, S-I Negoro, et al.
Molecular Cancer Therapeutics
|
December 7, 2002
DNA methylation profiles of lung tumors
S Toyooka, K O Toyooka, R Maruyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 1, 1996
[Phase I study on DMDC]
A Gemma, S Kudoh, M Fukuoka, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 211) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers
M Nishio, T Koshikawa, T Kuroishi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 18, 2005
Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer
Y Ohe, S Negoro, K Matsui, et al.
Journal of Neuroendocrinology
|
October 2, 2001
Polyamine regulation of the rat pro-opiomelanocortin gene expression in AtT-20 cells
E Yamamori, Y Iwasaki, Y Aoki, et al.
International Journal of Hematology
|
October 1, 1996
Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16. MST-16 Study Group
Y Kagami, Y Ariyoshi, A Horiuchi, et al.
Journal of the National Cancer Institute
|
October 28, 1998
Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer
T Mitsudomi, S Suzuki, Y Yatabe, et al.
Cancer Chemotherapy Reports
|
June 1, 1972
Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man
K Ota, S Kurita, M Nishimura, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1982
The response to endocrine therapy in patients with advanced breast cancer in Great Britain and Japan
J L Hayward, R D Rubens, S Sexton, et al.
British Journal of Cancer
|
January 8, 2004
Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)
N Yamamoto, M Fukuoka, S-I Negoro, et al.
Molecular Cancer Therapeutics
|
December 7, 2002
DNA methylation profiles of lung tumors
S Toyooka, K O Toyooka, R Maruyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 1, 1996
[Phase I study on DMDC]
A Gemma, S Kudoh, M Fukuoka, et al.
Page
of 22